Cimetidine Hcl



Indications and Reactions:

Role Indications Reactions
Primary
Dyspepsia 50.0%
Drug Use For Unknown Indication 16.7%
Gastrooesophageal Reflux Disease 16.7%
Hyperplasia 16.7%
Pulmonary Fibrosis 25.0%
Drug Ineffective 12.5%
Malignant Nipple Neoplasm Male 12.5%
Renal Failure Acute 12.5%
Transaminases Increased 12.5%
Urticaria 12.5%
Vomiting 12.5%
Secondary
Drug Use For Unknown Indication 51.0%
Intentional Drug Misuse 10.0%
Septic Shock 5.0%
Bacteroides Infection 4.0%
Ill-defined Disorder 4.0%
Liver Abscess 4.0%
Rheumatoid Arthritis 3.0%
Angina Pectoris 2.0%
Cardiovascular Disorder 2.0%
Fallopian Tube Cancer 2.0%
Gastritis 2.0%
Metastases To Lung 2.0%
Non-hodgkin's Lymphoma 2.0%
Abdominal Pain 1.0%
Colorectal Cancer 1.0%
Diabetes Mellitus 1.0%
Disseminated Intravascular Coagulation 1.0%
Hypercholesterolaemia 1.0%
Hypertension 1.0%
Pneumonia Bacterial 1.0%
Respiratory Arrest 26.7%
Platelet Count Decreased 10.0%
Medication Error 6.7%
Vomiting 6.7%
Weight Decreased 6.7%
Atrioventricular Block Complete 3.3%
Congenital Musculoskeletal Anomaly 3.3%
Drug Toxicity 3.3%
Haemolytic Anaemia 3.3%
Hyperkalaemia 3.3%
Multiple Drug Overdose 3.3%
Paraesthesia 3.3%
Rash 3.3%
Shock 3.3%
Skin Discolouration 3.3%
Therapeutic Response Unexpected 3.3%
Thrombocytopenia 3.3%
Unresponsive To Stimuli 3.3%
Concomitant
Drug Use For Unknown Indication 39.4%
Premedication 12.2%
Rheumatoid Arthritis 6.2%
Breast Cancer 5.1%
Prophylaxis 4.7%
Hypertension 3.4%
Antiemetic Supportive Care 3.2%
Non-small Cell Lung Cancer 3.0%
Urinary Tract Infection 3.0%
Breast Cancer Metastatic 2.4%
Depression 2.4%
Lung Neoplasm Malignant 2.1%
Chronic Obstructive Pulmonary Disease 1.9%
Cystitis 1.9%
Gastritis 1.7%
Ovarian Cancer 1.7%
Gastrooesophageal Reflux Disease 1.5%
Metastases To Bone 1.5%
Asthma 1.3%
Hypercholesterolaemia 1.3%
Rhabdomyolysis 16.0%
Vomiting 11.1%
Myocardial Infarction 7.4%
Trismus 6.2%
Infusion Related Reaction 4.9%
Sepsis 4.9%
Staphylococcal Infection 4.9%
Thrombocytopenia 4.9%
Chronic Tonsillitis 3.7%
Pancreatic Disorder 3.7%
Skin Exfoliation 3.7%
Skin Laceration 3.7%
Tooth Loss 3.7%
Type 2 Diabetes Mellitus 3.7%
White Blood Cell Count Decreased 3.7%
Wound Treatment 3.7%
Breast Cancer 2.5%
Colitis 2.5%
Diabetes Mellitus 2.5%
Febrile Neutropenia 2.5%